4-Hydroxynonenal (4HNE) is the most prevalent toxic lipid peroxidation product formed during oxidative stress. It exerts its cytotoxicity mainly by the modification of intracellular proteins. The detection of 4HNE-modified proteins in several degenerative disorders suggests a role for 4HNE in the onset of these diseases. Efficient protection mechanisms are required to prevent the intracellular accumulation of 4HNE. The toxicity of 4HNE was tested with the small cell lung cancer cell lines GLC % and the multidrug-resistance-protein (MRP1)-overexpressing counterpart GLC % \Adr. In the presence of the MRP1 inhibitor MK571 or the GSH-depleting agent buthionine sulphoximine, both cell lines became more sensitive and showed decreased survival. Transport experiments were performed with the $H-labelled glutathione S-conjugate of 4HNE ([$H]GS-4HNE) with membrane vesicles from GLC % -derived cell lines with different ex-
INTRODUCTION
Lipid peroxidation is a degenerative process affecting cell membranes and other lipid-containing structures and is associated with pathological implications [1] . It is initiated by reactive oxygen species (ROS) generated under conditions of oxidative stress. The conversion of polyunsaturated fatty acids by shortlived ROS results in the formation of relatively stable aldehydes that can diffuse from their site of origin and affect targets distant from the initial free radical attack. One of the major toxic products generated during lipid peroxidation is the α,β-unsaturated aldehyde 4-hydroxynonenal (4HNE), which is derived from ω-6 polyunsaturated fatty acids such as arachidonic acid and linoleic acid [1, 2] .
4HNE shows a variety of cytotoxic effects such as the inhibition of DNA, RNA and protein synthesis, cell cycle arrest, mitochondrial dysfunction, the induction of cataracts of the lens and neuronal apoptosis [2] [3] [4] . Intracellularly, 4HNE reacts rapidly with thiol groups of GSH and cysteine and with lysine and histidine residues of proteins [5, 6] . 4HNE-modified proteins have been detected in pathological disorders such as chronic liver diseases [7] , Parkinson's disease [8] , deficiency in mitochondrial complex I [9] , Alzheimer's disease [10] and atherosclerotic lesions [11] . Furthermore, 4HNE plasma levels are increased in patients with rheumatoid arthritis [12] .
Abbreviations used : BSO, buthionine sulphoximine ; GS-4HNE, glutathione S-conjugate of 4-hydroxynonenal ; GST, glutathione S-transferase ; 4HNE, 4-hydroxynonenal ; LTC 4 , leukotriene C 4 ; MDR1, multidrug resistance P-glycoprotein 1 ; MRP1, multidrug resistance protein ; PGA, prostaglandin A ; PNGase F, peptide N-glycosidase F ; p[CH 2 ]ppA, adenosine 5h-[β,γ-methylene]triphosphate ; ROS, reactive oxygen species. 1 To whom correspondence should be addressed (e-mail m.muller!med.rug.nl). Key words : ATP-dependent transport, detoxification, glutathione, oxidative stress.
It is obvious that efficient protection mechanisms are required to prevent the accumulation and the subsequently toxic effects of 4HNE. Enzymes primarily known for the metabolism and\or detoxification of 4HNE are aldehyde dehydrogenases, aldo-keto reductases and glutathione S-transferases (GSTs). These enzymes convert 4HNE into 4-hydroxynoneic acid, 1,4-dihydroxynonene or the GSH conjugate of 4HNE (GS-4HNE) [2, [13] [14] [15] . Of these metabolites, GS-4HNE is found predominantly when heart, liver or kidney is perfused with 4HNE [13, 16, 17] . This showed that GSH has a major role in the metabolism of 4HNE. GSH can react rapidly and spontaneously with 4HNE [5] , but the reaction is far more efficient when it is catalysed by GSTs, for example human GST A4-4 [15, 18] and rat GST A5-5 [19] .
The GSH\GST system is a well-known mechanism in the cellular defence against oxidative stress. The excretion of GSH conjugates is important in decreasing intracellular concentrations of toxins because conjugation reactions are reversible. In addition, some metabolites become toxic on conjugation with GSH [20] . GS-4HNE seems to be a product inhibitor for GST [18] and therefore the accumulation of GS-4HNE might lead to decreased detoxification capacities for 4HNE and other toxic metabolites. The extrusion of GS-4HNE is required for preventing these effects ; the existence of a transport mechanism has been proposed [21] . One of the best candidates for the transport of GS-4HNE across the cell membrane is the multidrug resistance protein MRP1. Together with GSH, MRP1 is expressed ubiquitously in the human body [20, 22] . Although MRP1 is primarily known for conferring multidrug resistance (MDR) on cancer cells by transporting anti-cancer drugs [23] , the best substrates identified for MRP1 so far have been endogenous GSH conjugates [24] . By analogy with MRP1, MRP2 is also a transporter with the highest affinity for GSH conjugates [24] and might also be a transporter for GS-4HNE [25] . MRP2 is predominantly found in liver and kidney, where MRP1 expression is relatively low [26] . In the present study we focused on MRP1.
In view of its ubiquitous expression and its substrate specificity, the putative physiological substrates of MRP1 seem to be GSHdependent detoxification products [27] . We hypothesize that GS-4HNE is a novel substrate for MRP1 and that MRP1, together with GSH, has a role in the defence against oxidative stress in the human body. 
EXPERIMENTAL

Generation of 4HNE
To obtain an aqueous solution of 4HNE, the precursor 4HNE-diethylacetal was hydrolysed by 1 mM HCl for 1 h at 37 mC. The concentration of 4HNE was determined by spectrophotometry at 224 nm.
Cell culture
The human small cell lung cancer cell line GLC % and its doxorubicin-selected multidrug-resistant counterparts GLC % \ 10x and GLC % \Adr were cultured as described [28] . These cells were used because of their different MRP1 expression levels. Sf 21 insect cells were cultured in Insect-XPRESS4 medium (Biowhittaker, Verviers, Belgium), supplemented with 0.5ipenicillin\ streptomycin\neomycin (PSN) and 5 % (v\v) foetal calf serum (Life Technologies). HF insect cells were cultured in Insect-XPRESS4 medium supplemented with 0.5iPSN.
Cell survival assay
To determine the cytotoxicity of 4HNE, the GLC % and GLC % \Adr cells were seeded at 100 000 cells\ml and grown overnight in either the absence or the presence of 25 µM of the γ-glutamylcysteine synthetase inhibitor buthionine sulphoximine (BSO). GLC % \Adr cells contain approximately twice as much GSH as do GLC % cells ; treatment with BSO decreased the GSH contents by approx. 75-80 % in both cell lines (results not shown) [29, 30] . Cells were collected by centrifugation (15 min at 1000 g), washed with Hanks buffered salt solution and seeded at similar densities in serum-free medium. Part of the cells was preincubated with 50 µM MK571 for 1 h before the addition of 4HNE. This MK571 concentration was not toxic to the cells. Cells were incubated with 4HNE (0-40 µM) for 4 h, collected by centrifugation and resuspended in a similar amount of serumsupplemented medium, then grown for a further 66 h. Cell survival was measured with 100 µl cell suspensions by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (' MTT ') assay.
Production of recombinant MRP1 and MDR1
The production of recombinant MRP1 and MDR1 protein was performed by the baculovirus expression system. A NotI-SalI fragment encoding the complete human MRP1 sequence was excised from the pJ3Ω-MRP vector and cloned into pFastBac1. Recombinant bacmids were generated in accordance with the manufacturer's instructions. Purified bacmids were transfected into Sf 21 insect cells by using CellFECTIN transfection reagent (Life Technologies). After 5 days the culture medium was used for a plaque assay. Single plaques were isolated, eluted into medium and used to infect fresh Sf 21 cells to increase the virus titre. Titres were determined by plaque assays ; virus stocks were stored at 4 mC. The MDR1 virus stock, provided by Dr U. S. Rao, was further amplified in Sf 21 cells to obtain larger amounts of virus stock. HF insect cells were used for the production of recombinant MRP1 and MDR1 proteins. (HF cells are supposed to have a higher protein expression yield than Sf 21 cells.) HF cells were seeded at a density of 3.5i10& cells\ml and infected with a multiplicity of infection of 5.0 and 7.0 plaque-forming units per ml for MRP1 and MDR1 respectively. After 62-64 h, cells were collected and membrane vesicles were isolated.
Isolation of membrane vesicles, deglycosylation and immunoblot analysis
Membrane vesicles used for transport studies were isolated from the GLC % , GLC % \10x and GLC % \Adr cells as described previously [31] . Membrane vesicles from the HF insect cells were isolated with the same protocol, except that the cells were lysed in 1 mM Tris\HCl (pH 7.2)\0.1 mM EDTA\0.1 mM PMSF instead of 1 mM NaHCO $ . Deglycosylation of membrane proteins was performed with a peptide N-glycosidase F (PNGase F) kit from New England Biolabs (NEB) (Beverly, MA, U.S.A.). Membrane vesicles (5-20 µg of protein) were incubated for 16 h at 37 mC in 50 mM sodium phosphate buffer, pH 7.5, containing 3 mM PMSF in the absence or the presence of 500 NEB-defined units of PNGase F. Immunoblot analysis of MRP1 and MDR1 expression in the membrane vesicles was performed essentially as described [31] .
Generation of GS-4HNE
Dithiothreitol was removed from the [$H]GSH solution by extraction with ethylacetate. The [$H]GSH conjugate of 4HNE ([$H]GS-4HNE) was formed by the incubation of a 10-fold molar excess of 4HNE with [$H]GSH in the presence of 100 mM Tris\HCl, pH 7.2, and 2 units of rat liver GST. The reaction was performed at 37 mC for 1 h with gentle shaking. Unlabelled GS-4HNE was generated by incubating freshly prepared GSH with 4HNE in a 1 : 1 molar ratio in the presence of 20 mM potassium phosphate buffer, pH 6.8. This reaction was performed for 2.5 h at 37 mC with gentle shaking. The reaction mixtures were spotted on TLC plates (Merck, Darmstadt, Germany) and developed in a chamber containing propan-1-ol\water\acetic acid (10 : 5 : 1, by vol.). The GS-4HNE conjugates were extracted from the plates and eluted in 70 % (v\v) ethanol. The extracts were dried in a Speed-Vac, dissolved in a small volume of 70 % (v\v) ethanol and stored at k20 mC. The concentration of [$H]GS-4HNE was determined by scintillation counting. The concentration of GS-4HNE was measured by a colorimetric assay with ninhydrin [32] . Nonyl-glutathione was used as a standard.
Transport studies
The uptake of [$H]GS-4HNE into membrane vesicles was measured as described [31] . In brief, membrane vesicles (10-25 µg of protein) were rapidly thawed and added to a buffer containing either 4 mM ATP or the non-hydrolysable ATP analogue (Table 1) . 
RESULTS
Cytotoxicity of 4HNE in GLC 4 and GLC 4 /Adr cells
Uptake of [ 3 H]GS-4HNE into membrane vesicles with different MRP1 expression
We hypothesized that MRP1 is a transporter for GS-4HNE. We therefore isolated membrane vesicles from cells with different levels of MRP1 expression and measured the uptake of [$H]GS-4HNE. MRP1 levels in the isolated membrane vesicles were analysed by immunoblotting (Figure 1 ). GLC % , GLC % \10x and GLC % \Adr membrane vesicles showed respectively low, intermediate and high expressions of MRP1. ATP-dependent uptake of [$H]GS-4HNE into membrane vesicles from these three cell lines was measured for 5 min (Figure 2 ) : the uptake of [$H]GS-4HNE was 0.4, 6.7 and 11.8 pmol\mg of protein respectively for GLC % , GLC % \10x and GLC % \Adr cells. This ATP-dependent uptake was completely inhibited by MK571 (10 µM final concentration). The uptake rate of [$H]GS-4HNE was correlated with levels of MRP1 expression. As control, membrane vesicles from A2780 ovarian tumour cells and their MDR1-overexpressing counterpart A2780AD, both with basal MRP1 expression [31] , showed only marginal ATP-dependent [$H]GS-4HNE uptake (results not shown). 
Figure 4 ATP-dependent uptake of [ 3 H]GS-4HNE into membrane vesicles from High Five (HF) insect cells overexpressing recombinant MRP1 and MDR1
Time course of ATP-dependent uptake of 
Production of recombinant MRP1
To demonstrate MRP1-specific [$H]GS-4HNE transport, recom- N-linked glycosylation, decreased the molecular mass of MRP1 from GLC % \Adr membrane vesicles to a mass similar to that from MRP1 expressed in untreated HF(MRP1) membrane vesicles ( Figure 3) . Treatment of HF(MRP1) membrane vesicles with PNGase F did not further decrease the molecular mass of MRP1 (results not shown). These results suggest that MRP1 expressed in HF cells is not, or is only partly, glycosylated.
Characterization of [ 3 H]GS-4HNE transport by recombinant MRP1
ATP-dependent uptake of [$H]GS-4HNE into HF(MRP1) membrane vesicles was linear for 1 min and was increased by up to 11-fold compared with that of HF or HF(MDR1) membrane vesicles ( Figure 4 ). To characterize further the ATP-dependent uptake of [$H]GS-4HNE into HF(MRP1) membrane vesicles, we studied the effect of several inhibitors of MRP1-mediated transport ( Table 2 ). Inhibition of [$H]GS-4HNE uptake increased with the length of the alkyl chain of the GS-derivative, and varied from undetectable (methyl-glutathione and propylglutathione) to highly effective (nonyl-glutathione). GSH did not inhibit [$H]GS-4HNE uptake, whereas GSSG was a weak inhibitor. MK571 inhibited [$H]GS-4HNE uptake in a dosedependent manner. Together with the results presented in Figure  2 , these results demonstrate that [$H]GS-4HNE is transported by MRP1.We examined the kinetics of MRP1-mediated [$H]GS-4HNE transport and determined an apparent K m of 1.6p0.21 µM and a V max of 804.5p28.8 pmol\min per mg of protein ( Figure 5 ).
DISCUSSION
ROS are formed under physiological conditions in eukaryotic cells as a consequence of aerobic metabolism. ROS can cause lipid peroxidation and the formation of potentially toxic aldehydes such as 4HNE [2] . Endogenously formed adducts of 4HNE with deoxyguanosine have been detected and are supposed Multidrug-resistance-protein-1-mediated protection against 4-hydroxynonenal to be involved in ROS-mediated tumour promotion [33] . In addition, at low concentrations, 4HNE seems to have a role in cell proliferation and differentiation [34] [35] [36] . Under conditions of oxidative stress the formation of ROS is strongly increased and this leads to a propagated generation of lipid peroxidation products with increased levels of 4HNE [1, 2] . 4HNE causes cellular damage mainly by the modification of intracellular proteins [6, 37] . The detection of 4HNE-modified proteins in early stages of degenerative diseases implies that 4HNE could have a role in the onset of these disorders. Efficient protection mechanisms preventing the accumulation of 4HNE are therefore required.
GSH is present in all eukaryotic cells and serves as a protection mechanism against ROS-induced toxic intermediates, either by reduction or by conjugation [20] . 4HNE is conjugated with GSH and in this study we have shown that MRP1 is a transporter for GS-4HNE and thus can function as an export mechanism. This is consistent with the idea of a cardiac export system for GS-4HNE that might in fact be MRP1 [21] . Factors that have a role in this detoxification pathway for 4HNE are GSH ( [5] , and this study), GST [18] and MRP1 (this study). GLC % and GLC % \Adr differ greatly in the expression of MRP1 but this is not correlated with sensitivity to 4HNE in these cells. Thus under basal conditions GSH and GST seem to be the dominant factors in the protection against 4HNE. However, on inhibition of MRP1, GLC % and GLC % \Adr cells become more sensitive to 4HNE showing that MRP1 does indeed have a role in the defence against 4HNE toxicity but, again, little difference is seen between the two cell lines. We therefore conclude that GSH, GST and MRP1 are interdependent factors and that, although MRP1 clearly has a role in defence against 4HNE toxicity, it does so in conjunction with GSH and GST. For example, inhibition of MRP1 leads to the accumulation of GS-4HNE ; this might cause product inhibition of GST and thus an increase in the intracellular concentration of 4HNE.
In the present study we have demonstrated that GS-4HNE is a novel MRP1 substrate. We used a baculovirus expression system to demonstrate MRP1-specific GS-4HNE transport. MRP1 expressed in HF insect cells is not glycosylated. Consistent with a previous study with Sf 21 insect cells, this does not influence the transport capacity of MRP1 [38] . Compared with the K m values of other MRP1 substrates, the K m that we found for MRP1-mediated GS-4HNE transport suggests that GS-4HNE is an MRP1 substrate with a relatively high affinity [24] . N-alkyl GSH conjugates are potent inhibitors of GSTs [39] . For example, 200 µM n-octyl-glutathione results in an approx. 80 % inhibition of the GSTs. The efficient removal of such products from GST is necessary to prevent product inhibition [21] . Because of the low K m of MRP1 for GS-4HNE, we conclude that MRP1 will effectively contribute to a rapid diminution in the inhibitory effects of GSH conjugates such as the oxidative stress product GS-4HNE.
MRP1 shows a substrate specificity highly similar to that of MRP2 [24] . In contrast with MRP2, MRP1 is expressed at low levels in normal liver and is localized at basolateral membranes, whereas MRP2 is located at canalicular membranes. The detection of GS-4HNE in bile after the administration of 4HNE [40] suggests that GS-4HNE might also be a substrate for MRP2 and that MRP2 might have a role in the detoxification of 4HNE in the liver by extrusion of GS-4HNE into bile.
MRP1 was originally identified in drug-resistant tumour cells ; research has focused on its capacity to confer drug resistance [41] . Overexpression of MRP1 is associated with resistance against the anthracycline doxorubicin [42] . Although MRP1 is a transporter for anthracyclines [29, 31] , doxorubicin resistance levels from MRP1-overexpressing cells often are not correlated with a decrease in its intracellular accumulation [43, 44] . Doxorubicin is known to generate ROS ; increased 4HNE formation has been observed after doxorubicin administration [45] . In addition, transfection with a GST isoenzyme with a high affinity for 4HNE resulted in resistance to doxorubicin [46] . MRP1 might therefore also have a role in doxorubicin resistance by the export of endogenously formed GS-4HNE.
Leukotriene C % (LTC % ) and prostaglandin A-glutathione (PGA-GS) are two other endogenously formed GSH conjugates that are efficiently transported by MRP1 [47, 48] . LTC % is important in the inflammatory response [49] and PGA causes cell cycle arrest and apoptosis [50, 51] . A tight regulation of the intracellular concentrations of LTC % and PGA is required to retain the response to inflammatory stimuli and to prevent toxic effects. MRP1-mediated GSSG transport suggested that MRP1 might also be involved in protection against oxidative stress [52] . The oxidative-stress-mediated induction of the genes encoding MRP1 and γ-glutamylcysteine synthetase, the rate-limiting enzyme in GSH synthesis, supports this [53] . GSSG is generated by the GSH-mediated reduction of ROS ; MRP1, as GSSG transporter, prevents intracellular GSSG accumulation and might function in maintaining the cellular redox state [20] . In this study we have demonstrated that MRP1 protects against the toxicity of one of the most important metabolites formed during oxidative stress. On the basis of its ubiquitous expression and its substrate specificity, the physiological functions of MRP1 seem to be the cellular extrusion of GSH-dependent detoxification products and involvement in the regulation of the cellular redox homoeostasis [27] .
In conclusion, we have shown that GS-4HNE is a novel MRP1 substrate and that MRP1 protects against 4HNE toxicity, most probably by extrusion of its GSH conjugate. We propose that MRP1, in conjunction with GSH, functions as a ubiquitous protection mechanism against oxidative stress.
